The FDA (Food and Drug Administration) revealed that certain diabetes medications had been linked to cases of an unusual, possibly life-threatening flesh-eating genital issues. The warning comes after the FDA discovered cases of the disease in patients taking a sodium-glucose cotransporter-2 (SGLT2) inhibitor throughout five years, between March 2013 to May 2018.

The infection that caused the caution is “necrotizing fasciitis of the perineum,” also referred to as “Fournier’s gangrene.” The rare infection affects the genital region, and it has a mortality rate of a lot more than 20 percent, based on a 2012 study released by ISRN Surgery in addition to the National Library of Medicine.

On August 29th, 2018, the FDA released an inventory of a dozen drugs that will need to carry a warning of the infection. On the list of brand names mentioned:
• Invokana

• Farxiga

• Xigduo

• Qtern

• Jardiance

• Synjardy

• Steglatro

• Steglujan

• Segluromet

• Glyxambi

Reference
http://diabetes-drug-infection.injury-check.com/. https://diabetes-drug-infection.injury-check.com/